Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.24 SEK | -2.64% | +8.20% | +118.68% |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Ljung
CEO | Chief Executive Officer | 44 | 05-12-31 |
Mark Beveridge
DFI | Director of Finance/CFO | 46 | 14-12-31 |
Chief Tech/Sci/R&D Officer | 60 | 22-12-31 | |
Sales & Marketing | 62 | 19-01-07 | |
Annica Magnusson
LAW | General Counsel | 61 | 19-01-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Lundmark
BRD | Director/Board Member | 66 | 22-05-15 |
Håkan Wallin
BRD | Director/Board Member | 62 | 23-05-15 |
Nikolaj Sørensen
BRD | Director/Board Member | 52 | 20-12-31 |
Chairman | 64 | 22-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,407,452 | 19,288,290 ( 67.90 %) | 445,974 ( 1.570 %) | 67.90 % |
Company contact information
Moberg Pharma AB
Gustavslundsvägen 50 5th Floor
167 51, Bromma
+46 8 52 23 07 00
http://www.mobergderma.seGroup companies
Name | Category and Sector |
---|---|
Moberg Derma Incentives AB
| |
Pharmaceuticals: Major
|
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+118.68% | 87.54M | |
+24.35% | 653B | |
+25.34% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.68% | 233B | |
+5.30% | 201B | |
-9.98% | 193B | |
-6.47% | 144B |
- Stock Market
- Equities
- MOB Stock
- Company Moberg Pharma AB